Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

<i>Letter:</i> Assessing Information and Misinformation About Diaper Dermatitis Treatment on TikTok.

Dermatitis : contact, atopic, occupational, drug·2026

Same author

A Vesiculopustular Skin Eruption.

Rhode Island medical journal (2013)·2025

Same author

Perception, Quality, and Accuracy of Sunscreen Content on TikTok: SkinMedia Cross-Sectional Content Analysis.

JMIR dermatology·2025

Same author

Landscape analysis of the United States dermatology workforce.

Journal of the American Academy of Dermatology·2025

Same author

Aggressive Amelanotic Melanoma Masquerading as Squamous Cell Carcinoma.

Rhode Island medical journal (2013)·2025

Same author

Classification of Kaposi Sarcoma Subtype in a Patient from Cape Verde.

Rhode Island medical journal (2013)·2025

Search research articles

Related Experiment Video

Updated: May 20, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Prognostic factors for melanoma.

Oliver J Wisco¹, Arthur J Sober

¹Dermatology Clinic, 81st Medical Group, 81 MDOS/SGOMD, 301 Fisher Street, Keesler AFB, MS 39534, USA. wiscooj@gmail.com

Dermatologic Clinics

|July 18, 2012

Summary

This summary is machine-generated.

This article explains the American Joint Committee on Cancer (AJCC) melanoma staging system for patient prognosis. It also covers other prognostic factors and recent genetic biomarker advancements for melanoma.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Experiment Videos

Last Updated: May 20, 2026

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Area of Science:

Oncology
Dermatology
Cancer Research

Background:

The American Joint Committee on Cancer (AJCC) staging system is the current standard for determining melanoma prognosis.
Accurate melanoma prognosis is crucial for guiding patient treatment and management.
Understanding prognostic factors aids in predicting patient outcomes and survival rates.

Purpose of the Study:

To detail the components of the AJCC melanoma staging system relevant to patient prognosis.
To summarize key clinical and histologic factors influencing melanoma prognosis.
To review emerging genetic biomarkers for improved melanoma prognosis.

Main Methods:

Review of the current AJCC melanoma staging criteria.
Synthesis of established clinical and histologic prognostic factors in melanoma.
Literature review of recent advancements in genetic biomarkers for melanoma prognosis.

Main Results:

The AJCC staging system provides a framework for melanoma prognosis.
Clinical and histologic factors significantly impact melanoma patient outcomes.
Genetic biomarkers show promise for refining melanoma prognosis.

Conclusions:

The AJCC staging system remains fundamental for melanoma prognosis.
A comprehensive understanding of prognostic factors is essential for effective melanoma management.
Advancements in genetic biomarkers offer potential for more precise melanoma prognostication.